20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T37078 | VEGFR-2-IN-6 | VEGFR | |
VEGFR-2-IN-6 (WO 02/059110, example 64) is a potent inhibitor of VEGFR2, a crucial receptor involved in the regulation of angiogenesis [1]. | |||
T10123 | VEGFR-2-IN-9 | KDR-in-4 | VEGFR |
VEGFR-2-IN-9 (KDR-in-4) is a potent KDR/VEGFR2 inhibitor (IC50: 7 nM). It can be used to study breast cancer. | |||
T9979 | VEGFR-2-IN-29 | VEGFR | |
VEGFR-2-IN-29 is a VEGFR2 inhibitor. | |||
T2056 | VEGFR-2-IN-5 | 2, 4-Pyrimidinediamine with linker,UNC0064-12,2,4-Pyrimidinediamine with linker | VEGFR |
VEGFR-2-IN-5 (UNC0064-12), multikinase inhibitor and has a -NH2 terminal linker for further synthesis. | |||
T40581 | TIE-2/VEGFR-2 kinase-IN-2 | ||
TIE-2/VEGFR-2 kinase-IN-2 is a powerful inhibitor of both VEGFR2 and Tie-2 kinases, displaying noteworthy pIC 50 values of 8.61 and 8.56, respectively. This compound acts as an anti-angiogenic agent, making it highly rel... | |||
T79860 | TIE-2/VEGFR-2 kinase-IN-5 | VEGFR , Tie-2 | |
TIE-2/VEGFR-2 kinase-IN-5 is a potent TIE-2 and VEGFR-2 tyrosine kinase receptor inhibitor with anti-angiogenic activity and is commonly used in biomedical research related to angiogenesis. | |||
T8817 | TIE-2/VEGFR-2 kinase-IN-1 | ||
TIE-2/VEGFR-2 kinase-IN-1 is used for the synthesis of TIE-2 and/or VEGFR-2 inhibitors that can be used for the study of diseases associated with inappropriate angiogenesis [1]. | |||
T9724 | VEGFR2-IN-2 | Others | |
VEGFR2-IN-2 has anti-inflammatory and analgesic activities. | |||
TP1474 | LXW7 | Integrin | |
LXW7 is an octamer disulfide cyclic peptide and αvβ3 integrin ligand, acts as a potent and specific endothelial progenitor cells (EPCs) and endothelial cells (ECs) targeting ligand. LXW7 is a disulfide cyclic octa-pepti... | |||
T8213 | Isolinderalactone | NOS , STAT | |
Isolinderalactone shows anti-inflammatory and anticancer capacity, and it exhibits moderate iNOS inhibitory activity, with the IC50 value of 0.30 uM. | |||
T22432 | SU5208 | 3-[(Thien-2-yl)methylene]-2-indolinone | VEGFR |
SU5208 (3-[(Thien-2-yl)methylene]-2-indolinone) is a compound with bioactivity.SU5208 inhibits vascular endothelial growth factor receptor-2 (VEGFR2). | |||
T22349 | JNJ-38158471 | CS-2660 | VEGFR , c-RET , c-Kit |
JNJ-38158471 (CS-2660), a highly selective, orally available, well tolerated VEGFR2 inhibitor with IC50 of 40 nM, inhibits closely related tyrosine kinases such as Ret and Kit with IC50 of 180 nM and 500 nM. | |||
T22431 | SU5204 | 3-[(2-Ethoxyphenyl)methylidene]-1H-indol-2-one | EGFR , VEGFR , HER |
SU5204 (3-[(2-Ethoxyphenyl)methylidene]-1H-indol-2-one), an analogue of SU5025, pharmacologically inhibits VEGFR2(IC50s of 4 and 51.5 μM for FLK-1 (VEGFR-2) and HER2) | |||
T5349 | SCR-1481B1 | c-Met inhibitor 2 | VEGFR , c-Met/HGFR |
SCR-1481B1 (c-Met inhibitor 2) has activity against cancers dependent on Met activation and also has activity against cancers as a VEGFR inhibitor | |||
T64060 | VEGFR-2-IN-21 | ||
VEGFR-2-IN-21 is a potent inhibitor of VEGFR-2 (IC50: 0.10 μM) and exhibits anticancer effects. | |||
T62071 | VEGFR-2-IN-16 | ||
VEGFR-2-IN-16 (Compound 15b) is a potent inhibitor of VEGFR-2 (IC50: 86.36 nM) that exhibits antitumour effects. | |||
T62901 | VEGFR-2-IN-27 | ||
VEGFR-2-IN-27 (compound 7a) is a potent inhibitor of VEGFR-2 (IC50: 14.8 nM) and can be used in anticancer studies. | |||
T61561 | VEGFR-2-IN-18 | ||
VEGFR-2-IN-18 (Compound 15d) is a high-potency inhibitor of VEGFR-2, with an IC 50 value of 60 nM. This compound effectively initiates cell apoptosis and demonstrates significant antitumor properties [1]. | |||
T78819 | VEGFR-2-IN-33 | VEGFR | |
VEGFR-2-IN-33 (Compound 4d), a potent VEGFR inhibitor with an IC50 value of 61.04 nM, demonstrates significant inhibition of HepG2 cell proliferation, achieving an IC50 of 4.31 nM. This compound is utilized for hepatocel... | |||
T63822 | VEGFR-2-IN-22 | ||
VEGFR-2-IN-22 (Compound 25) is an inhibitor of VEGFR-2 and β-tubulin polymerization with an IC50=19.82 nM for VEGFR-2. VEGFR-2-IN-22 is capable of inducing apoptosis. |